Related references
Note: Only part of the references are listed.Phorbol ester-induced PKCε down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation
Giuliana Gobbi et al.
BLOOD (2009)
The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation
Shannon C. Jackson et al.
BLOOD (2009)
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with vonWillebrand disease type 2B: a cohort study of 67 patients
Augusto B. Federici et al.
BLOOD (2009)
Exposure of human megakaryocytes to high shear rates accelerates platelet production
Claire Dunois-Larde et al.
BLOOD (2009)
Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization
L. Baronciani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano
A. Balduini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
A functional 14-3-3ζ-independent association of PI3-kinase with glycoprotein Ibα, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex
Fi-Tjen Mu et al.
BLOOD (2008)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow
William B. Slayton et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes
A. Balduini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Timing and expression level of protein kinase cε regulate the megakaryocytic differentiation of human CD34 cells
Giuliana Gobbi et al.
STEM CELLS (2007)
Mechanics of proplatelet elaboration
J. E. Italiano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13
J. Rayes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia
Paquita Nurden et al.
BLOOD (2006)
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J. E. Sadler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS 13 deficiency and von Willebrand disease type 2B
JJJ Hulstein et al.
BLOOD (2005)
Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes
A Tomer
BLOOD (2004)
Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations
JJ Dumas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
M Chang et al.
BLOOD (2003)
Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome
T Kanaji et al.
BLOOD (2002)
Absence of GPIbα is responsible for aberrant membrane development during megakaryocyte maturation:: Ultrastructural study using a transgenic model
CR Poujol et al.
EXPERIMENTAL HEMATOLOGY (2002)
Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease
P Nurden et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
